Biomaterials Market Size Poised To Reach USD 348.4 Billion By 2027


 San Francisco, 15 Dec 2020: The Report Biomaterials Market Size, Share & Trends Analysis Report By Product (Natural, Metallic, Polymer), By Application (Cardiovascular, Orthopedics, Plastic Surgery), By Region, And Segment Forecasts, 2020 - 2027

The global biomaterials market size is expected to reach USD 348.4 billion by 2027, registering a CAGR of 15.9% over the forecast period, according to a new report by Grand View Research, Inc. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems.

Biocompatibility, low toxicity, and renewable nature of polymeric biomaterials make them potent drug delivery agents in controlled and targeted drug delivery, thus providing lucrative opportunities for the market growth. The advent of improved drug delivery approaches, such as PEG-coated liposomes, biopolymer-coated liposomes, and nanomaterials drug delivery, further expands the prospects of these biopolymers in the pharmaceutical and medical industries.

Use of biomaterials has greatly benefited the regeneration of the cardiopulmonary system. These materials provide physical support and physiological and chemical cues to seeded cells to assist the tissue regeneration process. Integration of biomaterials with nanotechnology techniques also stimulates the regeneration of damaged cardiomyocyte’s extracellular matrix, thus replacing the traditional organ transplantation procedures.

Access Research Report of Biomaterials Market https://www.grandviewresearch.com/industry-analysis/biomaterials-industry

Biomaterials Market Report Highlights

  • High availability of natural and synthetic degradable polymers and their wide usage as surgical sutures and implants resulted in the largest revenue share of the polymers product segment
  • Natural products have gained immense popularity as a source of novel bioactive substance for the development of novel drugs, leading to fastest growth of this segment
  • Increasing incidence of chronic skeletal and musculoskeletal conditions is expected to raise the demand for biomaterials for orthopedics application at a large scale
  • Improvement in the surface modification of silicone breast implants to prevent capsular contracture is one of the factors driving the biomaterial usage in the plastic surgery segment at the fastest rate
  • North America is expected to dominate the biomaterials market in terms of revenue share owing to the presence of public and private agencies promoting biomaterial usage by hosting events and funding initiatives
  • Asia Pacific is anticipated to grow at a rapid pace owing to the presence of several local manufacturers developing low-cost biomaterial products, mainly in China
  • Prominent players operating in the market include Medtronic, Evonik, DSM, BASF, Berkeley Advanced Biomaterials, Covalon Technologies, and Zimmer Biomet Holdings
  • Companies are engaged in several strategic growth initiatives, such as novel product developments, partnerships, and regional expansion to reinforce their market presence
  • For instance, in November 2019, Evonik partnered with BellaSeno GmbH for development and commercialization of 3D printed breast implant by using Evonik’s RESOMER bioresorbable polymer.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global biomaterials market on the basis of product, application, and region:

Biomaterials Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Metallic
  • Natural
  • Ceramics
  • Polymers

Biomaterials Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Cardiovascular
    • Sensors
    • Stents
    • Guidewires
    • Implantable Cardiac Defibrillators
    • Pacemakers
    • Vascular Grafts
    • Others
  • Ophthalmology
    • Synthetic Corneas
    • Intraocular Lens
    • Contact Lens
    • Ocular Tissue Replacement
    • Others
  • Dental
    • Tissue Regeneration Materials
    • Dental Implants
    • Bone Grafts & Substitutes
    • Dental Membranes
    • Others
  • Orthopedic
    • Joint Replacement biomaterials
    • Orthobiologics
    • Bioresorbable Tissue Fixation Products
    • Viscosupplementation
    • Spine Biomaterial
    • Others
  • Wound Healing
    • Fracture Healing Device
    • Adhesion Barrier
    • Skin Substitutes
    • Internal Tissue Sealant
    • Surgical Hemostats
    • Others
  • Tissue Engineering
  • Plastic Surgery
    • Facial Wrinkle Treatment
    • Soft Tissue Fillers
    • Craniofacial Surgery
    • Bioengineered Skins
    • Peripheral Nerve Repair
    • Acellular Dermal Matrices
    • Others
  • Neurology
    • Neural Stem Cell Encapsulation
    • Shunting Systems
    • Hydrogel Scaffold For CNS Repair
    • Cortical Neural Prosthetics
    • Others
  • Others

Biomaterials Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Access Press Release of Biomaterials Market @ https://www.grandviewresearch.com/press-release/global-biomaterials-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Comments

Popular posts from this blog

U.K. Point Of Sale Software Market To Expand Industry Growth At USD 1.05 Billion By 2028

Gas Detection Equipment Market Anticipated To Expand At A CAGR 9.7% From 2021 To 2028